Thinking of selling in this correction? Don’t. Act like a business owner instead. The pressure in today’s market environment is immense, and it can be tempting for investors to throw in the towel and sell even the best companies when their measure of success is short-term share price movements. Don't commit this big and costly mistake.

The real reason why investors are wrong to be spooked by big tech earnings. Since their 2021 peaks, the share prices of the world’s largest technology companies have recorded massive declines. Many investors, are thinking about offloading these stocks but the silver lining is that the pain is very likely only temporary.

In the current environment of heightened volatility, it’s vital that investors keep in mind the power of compounding. We use Buffett’s example in this article to highlight that the key to becoming very wealthy is strong compounding, repeated over time.

The potential for Moderna to exploit mRNA and massively expand its operational scope makes it a compelling investment opportunity that the market is failing to recognize.

In a complex, ever-changing world, where domain-specific information is becoming commoditised and readily available, ‘multidisciplinary’ investing has become one of the true sources of an investment edge. Interestingly, despite the undoubted power of multidisciplinary investing, the investment industry is still largely built on the principle of specialization.

Investors have been promised an elixir of big returns and low volatility. But the truth is that to achieve outstanding long-term returns, investors must be prepared to endure large drawdowns along the way – even for the best-performing stocks and portfolios.

Investors are well aware that equity markets have commenced 2022 with severe volatility and big price declines. Certain long-term winning businesses have recently become a lot cheaper. That is, less risky. We acknowledge that the drawdowns have been uncomfortable, as they always are. But understanding these as part of the natural journey to strong long-term compounding gives peace of mind to stay the course.

We do not argue that investing in China isn’t ‘risky’ per-se, but rather, investors are likely to be well-compensated for taking those risks. Looking at Alibaba, the reward to risk ratio is particularly strong making it a compelling investment opportunity.

Investors overlook and take for granted that silently sitting beneath the surface of Alphabet is perhaps the most cutting-edge AI apparatus the world has ever seen. Artificial Intelligence is enhancing all areas of Alphabet’s business, from those with valuable monetization models including Search, YouTube and Cloud, to emerging opportunities like autonomous driving (Waymo).

(As mentioned in the AFR) Montaka believes AI will drive much, much more demand for compute and storage – both in the cloud and at the edge – than many are expecting today. Furthermore, the long-term winners are already known today with a high degree of certainty and we believe the current stock prices of these businesses are failing to adequately reflect what Montaka’s sees on the horizon.

Investment specialist Matthew Briggs interviews Andy and Chris about our latest whitepaper on AI (artificial intelligence) and the reasons for selecting this topic.

– Chris Demasi   As Mike Tyson said, ‘everyone has a plan…until they get punched in the face’. That must be how a lot of investors feel just one month into 2022 after sharp falls in equity markets in January. But this recent bout of volatility and market weakness should not be a time to …

2022 investing game plan: The recent sell-off has put mega caps on sale Read More »